Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Endovascular AAA Repair Grows; Little To Choose Between Ancure, AneuRx

This article was originally published in The Gray Sheet

Executive Summary

Endovascular repair of abdominal aortic aneurysms continues to grow in popularity with the clinical community at the expense of the more invasive open surgical procedure, due in large part to word-of-mouth among patients, according to physicians.

You may also be interested in...



Industry Meeting With HCFA Aimed At Amending "Final" OPPS List By July 1

The device industry is hopeful that a meeting with Health Care Financing Administration officials - scheduled to have occurred May 19 - will result in the addition by July 1 of more devices to the agency's final list of new technology eligible for added reimbursement under the outpatient prospective payment system.

Edwards Lifesciences Lifepath AAA Graft Fracture Investigation Ongoing

Edwards Lifesciences is continuing to investigate the cause of fractures detected in the wireform scaffolding of its Lifepath endovascular graft system for treatment of abdominal aortic aneurysms, following discovery of the fractures in two patients treated with the device.

Bard Views GI, AAA Devices And Brachytherapy Seeds As Key Growth Drivers

Bard is hopeful that the Health Care Financing Administration will deem the firm's endoscopic suturing system for gastroesophageal reflux disease eligible for supplementary reimbursement under the agency's outpatient prospective payment system.

Related Content

UsernamePublicRestriction

Register

MT013396

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel